Artemisinin With Risperidone for First-Episode and Drug-Naive Schizophrenia
Condition(s):SchizophreniaLast Updated:July 12, 2016Completed
Hide Studies Not Open or Pending
Condition(s):SchizophreniaLast Updated:July 12, 2016Completed
Condition(s):Schizophrenia; Schizoaffective DisorderLast Updated:February 28, 2012Completed
Condition(s):Covid19Last Updated:September 9, 2021Completed
Condition(s):COVID-19Last Updated:March 16, 2021Unknown status
Condition(s):MalariaLast Updated:February 23, 2018Unknown status
Condition(s):Malaria; Malaria, Asymptomatic ParasitaemiaLast Updated:November 19, 2019Completed
Condition(s):Covid 19 Positive; Corona Virus InfectionLast Updated:May 2, 2022Withdrawn
Condition(s):Schistosomiasis HaematobiaLast Updated:February 11, 2020Completed
Condition(s):Plasmodium Falciparum; Malaria, FalciparumLast Updated:March 14, 2018Completed
Condition(s):Malaria, FalciparumLast Updated:May 9, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.